tiprankstipranks
Trending News
More News >
Medartis Holding AG (CH:MED)
:MED
Switzerland Market
Advertisement

Medartis Holding AG (MED) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

MED Financial Forecast

MED Earnings Forecast

The previous quarter’s earnings for MED were CHF0.08.
The previous quarter’s earnings for MED were CHF0.08.

MED Sales Forecast

Next quarter’s sales forecast for MED is CHF125.00M with a range of CHF125.00M to CHF125.00M. The previous quarter’s sales results were CHF113.30M. MED beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.47% of the time in the same period. In the last calendar year MED has Preformed in-line its overall industry.
Next quarter’s sales forecast for MED is CHF125.00M with a range of CHF125.00M to CHF125.00M. The previous quarter’s sales results were CHF113.30M. MED beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.47% of the time in the same period. In the last calendar year MED has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:MED
TipRanks AITipRanks
Not Ranked
TipRanks
CHF85
Buy
-1.05%
Downside
Reiterated
07/22/25
The overall stock score of 71 reflects Medartis Holding AG's strong technical momentum and solid financial stability, despite a high valuation. The company's robust revenue growth and improved cash flow positively impact the score, while the high P/E ratio suggests overvaluation risks. The absence of earnings call data and corporate events does not impact the score.
Stifel Nicolaus Analyst forecast on CH:MED
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
CHF86
Buy
0.12%
Upside
Reiterated
03/24/25
Positive Outlook for Medartis Holding AG: Strategic Initiatives and Financial Projections Support Buy Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:MED
TipRanks AITipRanks
Not Ranked
TipRanks
CHF85
Buy
-1.05%
Downside
Reiterated
07/22/25
The overall stock score of 71 reflects Medartis Holding AG's strong technical momentum and solid financial stability, despite a high valuation. The company's robust revenue growth and improved cash flow positively impact the score, while the high P/E ratio suggests overvaluation risks. The absence of earnings call data and corporate events does not impact the score.
Stifel Nicolaus Analyst forecast on CH:MED
Dylan Van HaaftenStifel Nicolaus
Stifel Nicolaus
CHF86
Buy
0.12%
Upside
Reiterated
03/24/25
Positive Outlook for Medartis Holding AG: Strategic Initiatives and Financial Projections Support Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medartis Holding AG

1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.40%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +3.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+3.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +3.70% per trade.
1 Year
Dylan Van HaaftenStifel Nicolaus
Success Rate
1/1 ratings generated profit
100%
Average Return
+17.90%
reiterated a buy rating 4 months ago
Copying Dylan Van Haaften's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +17.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+17.80%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +17.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MED Analyst Recommendation Trends

Rating
Mar 25
Jul 25
Strong Buy
0
0
Buy
2
7
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
2
7
In the current month, MED has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MED average Analyst price target in the past 3 months is 86.00.
Each month's total comprises the sum of three months' worth of ratings.

MED Stock Forecast FAQ

What is CH:MED’s average 12-month price target, according to analysts?
Based on analyst ratings, Medartis Holding AG’s 12-month average price target is 86.00.
    What is CH:MED’s upside potential, based on the analysts’ average price target?
    Medartis Holding AG has 0.12% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Medartis Holding AG a Buy, Sell or Hold?
          Medartis Holding AG has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Medartis Holding AG’s share price target?
            The average share price target for Medartis Holding AG is 86.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF86.00 ,and the lowest forecast is CHF86.00. The average share price target represents 0.12% Increase from the current price of CHF85.9.
              What do analysts say about Medartis Holding AG?
              Medartis Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Medartis Holding AG?
                To buy shares of CH:MED, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis